Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and …

M Gatti, M Rinaldi, G Ferraro, A Toschi, N Caroccia… - Mycoses, 2021 - Wiley Online Library
Introduction Although echinocandins are recommended as first‐line prophylaxis for high‐
risk orthotopic liver transplant (OLT) recipients, occurrence of breakthrough‐invasive fungal …

Development and Quality Control of a Population Pharmacokinetic Model Library for Caspofungin

N Xu, Y Shi, Y Wang, W Mak, W Yang, KW Ng, Y Wu… - Pharmaceutics, 2024 - mdpi.com
Background: Caspofungin is an echinocandin antifungal agent commonly used as the first-
line therapy for invasive candidiasis, salvage therapy for invasive aspergillosis, and …

[HTML][HTML] Human tissue distribution of caspofungin

J Marx, V Reinstadler, T Gasperetti, R Welte… - International Journal of …, 2022 - Elsevier
Tissue concentrations of caspofungin were determined in nine clinically relevant tissues
taken during routine autopsy of 20 patients who had died during caspofungin treatment or …

[引用][C] Target-site Pharmacokinetics and Pharmacodynamics of Echinocandins

T Gasperetti, R Bellmann